ClinicalTrials.gov
public full text
Public Domain
Fourth-generation Immucillin Derivative DI4G Associated Therapy in Cutaneous Leishmaniasis
A clinical trial to asses efficacy and safety of Transition-state Analog Inhibitor of Human Purine Nucleoside Phosphorylase for topical use associated standard antimonial in the treatment of Cutaneous Leishmaniasis in Bahia, Brazil.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Senescência e imunorregulação compõem nichos imunológicos distintos na imunopatogênese das leishmanioses cutânea localizada e difusa#1159565
- Efficacy Trial on Oral Miltefosine in Comparison With Glucantime in the Treatment of ACL Caused by L. Tropica#1010090
- Novel Isoxazole Functionalized Quinazolinone Derivatives and Their Anticancer Activity#1121785
- Deep and disseminated dermatophytosis in immunocompromised populations-A systematic review#1133232
- A Long-term Trial of OPA-15406 in Infants With Atopic Dermatitis#828069
Record · ID 1310204
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive